Articles From: ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial to ARM and Synopsys Collaboration Enables Optimized Implementation of ARM Cortex-A72 Processor-based SoCs with IC Compiler II


2014/12/9
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced long-term follow up data from the Phase 1 trial of Iclusig ® (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that with a median follow-up of four years in chronic phase CML (CP-CML) patients, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options and that responses have been maintained in CP-CML patients (n=43) with 72 percent having a major cytogenetic response (MCyR), 65 percent having a complete cytogenetic response (CCyR) and 56 percent having a major molecular response (MMR). Long-term safety data show that careful benefit-risk evaluations should guide decisions to use and maintain
Sign-up for ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial investment picks
2015/1/6
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it has concluded consultations with U.S. and European health authorities regarding the design of a randomized, dose-ranging trial to evaluate three starting doses of Iclusig ® (ponatinib) in patients with refractory, chronic-phase chronic myeloid leukemia (CP-CML). The trial is expected to inform the optimal use of Iclusig in these patients and will begin by mid-2015.
Sign-up for ARIAD Announces Phase 2 Dose-Ranging Trial of Iclusig (Ponatinib) to Begin by Mid-2015 investment picks
2015/2/20
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today confirmed that it has received notice of nomination by Sarissa Capital Management LP of two director candidates for election at the 2015 Annual Meeting.
Sign-up for ARIAD Confirms Receipt of Sarissa Capital Management’s Nomination of Director Candidates investment picks
2015/2/19
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the fourth quarter and full year ended December 31, 2014 and issued 2015 financial guidance.
Sign-up for ARIAD Reports 2014 Financial Results, Provides 2015 Financial Guidance and Outlines Strategic Objectives investment picks
2014/12/22
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 33 rd Annual J.P. Morgan Healthcare Conference being held in San Francisco.
Sign-up for ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/24
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Cowen and Company 35 th Annual Health Care Conference being held in Boston.
Sign-up for ARIAD to Present at the Cowen and Company 35th Annual Health Care Conference investment picks
2015/2/3
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Global Healthcare Conference being held in New York City.
Sign-up for ARIAD to Present at the Leerink Global Healthcare Conference investment picks
2015/2/11
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that it will present at the RBC Capital Markets’ Healthcare Conference being held in New York City.
Sign-up for ARIAD to Present at the RBC Capital Markets’ Healthcare Conference investment picks
2015/1/29
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its fourth quarter and year-end 2014 financial results and issue 2015 financial guidance on Thursday, February 19, 2015, before the market opens.
Sign-up for ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results investment picks
2014/12/2
Ariba ® Pay ™ is catching fire.
Sign-up for AribaPay Takes Off investment picks
2015/1/29
Time Inc. (NYSE:TIME) announced that Ariel Foxman has been promoted to Editorial Director, InStyle and StyleWatch, a new role at the company.
Sign-up for Ariel Foxman Promoted to Editorial Director of InStyle and StyleWatch investment picks
2014/12/10
Arista Networks announced today the addition of EOS+ , a software platform for network programmability and automation as an evolution of Arista EOS (Extensible Operating System). EOS+ provides an advanced level of programmability, allowing customers to take advantage of pre-built and custom EOS applications as well as integration with a wide range of technology partner solutions from A10 Networks , Ansible , Aruba , Cloudera , Nuage , Palo Alto Networks , Puppet Labs , Pure Storage , Red Hat , Splunk , VMTurbo , VMware and Zscaler .
Sign-up for Arista Introduces EOS+: Platform For Software Driven Cloud Networking investment picks
2014/12/1
Arista Networks, Inc. (NYSE:ANET) today announced participation in the following events with the financial community: Credit Suisse Technology Conference Kelyn Brannon, CFO Phoenix, AZ Thursday, December 4, 2014 8:30am PT / 11:30am ET Raymond James S4 Conference Kelyn Brannon, CFO New York, NY Monday, December 8, 2014 12:00pm PT / 3:00pm ET Barclays Annual Tech Conference Jayshree Ullal, President and CEO San Francisco, CA Tuesday, December 9, 2014 12:45pm PT / 3:45pm ET Bernstein Emerging Tech Conference Kelyn Brannon, CFO Boston, MA Tuesday, December 16, 2014 8:00am PT / 11:00am ET A live audio webcast of these events will be accessible from the "Investors" section of Arista Networks website at investors.arista.com .
Sign-up for Arista Networks Announces Participation in Upcoming Investor Events for December investment picks
2015/1/13
Arista Networks, Inc. (NYSE:ANET) today announced participation in the following events with the financial community: 17 th Annual Needham Growth Conference Kelyn Brannon, CFO New York, NY Thursday, January 15, 2015 6:20am PT / 9:20am ET Goldman Sachs Technology and Internet Conference 2015 Andy Bechtolsheim, Founder, CDO and Chairman San Francisco, CA Tuesday, February 10, 2015 8:15am PT / 11:15am ET Stifel Technology, Internet & Media Conference Kelyn Brannon, CFO San Francisco, CA Tuesday, February 10, 2015 1:50pm PT / 4:50pm ET A live audio webcast of these events will be accessible from the "Investors" section of Arista Networks website at investors.arista.com .
Sign-up for Arista Networks Announces Participation in Upcoming Investor Events for January and February investment picks
2015/2/19
Arista Networks, Inc. (NYSE: ANET), an industry leader in software-driven cloud networking solutions for large data center and computing environments, today announced financial results for its fourth quarter and year ended December 31, 2014.
Sign-up for Arista Networks Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/6
Arista Networks, Inc. (NYSE:ANET) will release its financial results for the quarter and fiscal year ended December 31, 2014 after U.S. markets close on Thursday, February 19 th .
Sign-up for Arista Networks to Announce Q4 and Fiscal Year 2014 Financial Results on Thursday, February 19th investment picks
2014/12/22
Ark Restaurants Corp.
Sign-up for Ark Restaurants Announces Conference Call investment picks
2015/2/9
Ark Restaurants Corp.
Sign-up for Ark Restaurants Announces Conference Call investment picks
2014/12/15
Ark Restaurants Corp.
Sign-up for Ark Restaurants Announces Declaration of Dividend investment picks
2015/2/9
Ark Restaurants Corp.
Sign-up for Ark Restaurants Announces Financial Results for the First Quarter of 2015 investment picks
2014/12/19
Ark Restaurants Corp.
Sign-up for Ark Restaurants Announces Financial Results for the Fourth Quarter and Full Year of 2014 investment picks
2014/12/31
The Arkansas Department of Higher Education (ADHE), in partnership with the Information Network of Arkansas , today announced the launch of a new “College for You” financial aid website.
Sign-up for Arkansas Launches New “College For You” Financial Aid Website investment picks
2015/2/3
ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. Appoints Anthony P. Nader as New Independent Director investment picks
2014/12/18
ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. Declares $0.875 per Share Dividend for the Fourth Quarter of 2014 investment picks
2015/2/3
Non-GAAP core operating income of $1.40 per share (diluted) for the fourth quarter 2014(1) or $5.19 per share (diluted) for the year ended December 31, 2014 GAAP net loss of $32.8 million (includes $27.5 million of tax provision) for the fourth quarter 2014, or GAAP net income of $6.0 million (includes $49.4 million of tax provision) for the year ended December 31, 2014 Dividend of $0.875 per share for the fourth quarter 2014, paid on January 30, 2015 Annualized dividend yield of 13%(2), 18%(3) on a tax adjusted basis Book value per share at December 31, 2014 was $27.95 ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/1/29
ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. to Report Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/24
ARM has expanded its technical training portfolio to include live courses that can be remotely-delivered in any location.
Sign-up for ARM Adds Customized Remote Training to Education Portfolio investment picks
2015/2/2
Collaboration enables reduced system bandwidth and power requirements while delivering a rich visual experience SAN JOSE, Calif.
Sign-up for ARM and Cadence Provide Energy-Efficient, Comprehensive Media Components for Mobile Market investment picks
2015/2/16
ARM and Green Hills Software announce they have collaborated on an optimized compiler for the ARM ® Cortex ® -R5 processor that delivers record-setting automotive performance, enabling the Cortex-R5 processor to meet the needs of the most challenging automotive applications more cost-effectively than any other MCU solution currently available.
Sign-up for ARM and Green Hills Software Deliver Best in Class Automotive Performance investment picks
2015/2/3
Synopsys' Design Solutions Enable Realization of Premium Mobile Experience with ARM's New Suite of IP MOUNTAIN VIEW, Calif.
Sign-up for ARM and Synopsys Collaboration Enables Optimized Implementation of ARM Cortex-A72 Processor-based SoCs with IC Compiler II investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial to ARM and Synopsys Collaboration Enables Optimized Implementation of ARM Cortex-A72 Processor-based SoCs with IC Compiler II
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent